YCMGA
TEVA icon

York Capital Management Global Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

York Capital Management Global Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-899,782
Closed -$59.1M – 93
2015
Q4 		$59.1M Buy
+899,782
New +$55.6M 0.88% 37
2014
Q2 		– Sell
-1,871,677
Closed -$98.9M – 112
2014
Q1 		$98.9M Buy
+1,871,677
New +$86.5M 1.15% 29

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

York Capital Management Global Advisors's TEVA Position: Q1 2016 in Review

York Capital Management Global Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 899,782 shares — an estimated $59.1M sold.

York Capital Management Global Advisors first reported a position in TEVA in Q1 2014 and held it in 2 quarters. The position peaked at $98.9M in Q1 2014. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

  • York Capital Management Global Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • York Capital Management Global Advisors sold 899,782 Teva Pharmaceuticals shares in Q1 2016, an estimated $59.1M.
  • York Capital Management Global Advisors first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • York Capital Management Global Advisors's Teva Pharmaceuticals position peaked at $98.9M in Q1 2014.
  • 836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on York Capital Management Global Advisors's 13F filing for Q1 2016, filed 16 May 2016.